Crossmark

RETRACTED ARTICLE: Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting

Crossref DOI link: https://doi.org/10.1038/s41417-022-00459-0

Published Online: 2022-03-30

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nie, Yichu

Feng, Fenglan

Luo, Wei

Sanders, Andrew J.

Zhang, Yidi

Liang, Jiaming

Chen, Cheng

Feng, Weineng

Gu, Weiquan

Liao, Weiping

Wang, Wei

Chen, Jinfeng

Zhang, Lijian

Jiang, Wen G.

Li, Jin https://orcid.org/0000-0002-7182-7510
License Information

Text and Data Mining valid from 2022-03-30

Version of Record valid from 2022-03-30
More Information

Article History

Received: 21 September 2021

Revised: 26 February 2022

Accepted: 9 March 2022

First Online: 30 March 2022

Change Date: 13 October 2023

Change Type: Correction

Change Details: This article has been retracted. Please see the Retraction Notice for more detail:

Change Details: https://doi.org/10.1038/s41417-023-00677-0

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below